AI Science Tracker
EN

Automated Prediction of Ischemic Brain Tissue Fate from Multiphase Computed Tomographic Angiography in Patients with Acute Ischemic Stroke Using Machine Learning.

University of Calgary · 31 May 2021 · medicine

Discovery

Automated Prediction of Ischemic Brain Tissue Fate from Multiphase Computed Tomographic Angiography in Patients with Acute Ischemic Stroke Using Machine Learning.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine learning predicted ischemic tissue fate from multiphase CT angiography in acute-stroke patients. The publisher Methods and Results were checked; this conclusion is limited to the study cohort, reference standard and validation described there. External replication and prospective utility were not established in the reviewed material.

Technology: Machine learning predicted ischemic tissue fate from multiphase CT angiography in acute-stroke patients.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine learning predicted ischemic tissue fate from multiphase CT angiography in acute-stroke patients.
Test and result
Machine learning predicted ischemic tissue fate from multiphase CT angiography in acute-stroke patients. The publisher Methods and Results were checked; this conclusion is limited to the study cohort, reference standard and validation described there.
Limitation / still unknown
External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8189856/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.